Evidence map›Paper›PMID 26762462›Full record

ArticleNature2016

Synthetic cycle of the initiation module of a formylating nonribosomal peptide synthetase.

Janice M Reimer, Martin N Aloise, Paul M Harrison, T Martin Schmeing

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Animal-Encoded Nonribosomal Pathway to Bursatellin Analogs.Journal of the American Chemical Society · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Structural Studies of Modular Nonribosomal Peptide Synthetases.Methods in molecular biology (Clifton, N.J.) · 2023
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Janice M ReimerDepartment of Biochemistry, McGill University, 3649 Promenade Sir-William-Osler, Montréal, Québec H3G 0B1, Canada.
Martin N AloiseDepartment of Biochemistry, McGill University, 3649 Promenade Sir-William-Osler, Montréal, Québec H3G 0B1, Canada.
Paul M HarrisonDepartment of Biology, McGill University, 1205 Dr Penfield Avenue, Montréal, Québec H3A 1B1, Canada.
T Martin SchmeingDepartment of Biochemistry, McGill University, 3649 Promenade Sir-William-Osler, Montréal, Québec H3G 0B1, Canada.

Funding

Canadian Institutes of Health Research 106615
6 · The paper itself

Abstract

Nonribosomal peptide synthetases (NRPSs) are very large proteins that produce small peptide molecules with wide-ranging biological activities, including environmentally friendly chemicals and many widely used therapeutics. NRPSs are macromolecular machines, with modular assembly-line logic, a complex catalytic cycle, moving parts and many active sites. In addition to the core domains required to link the substrates, they often include specialized tailoring domains, which introduce chemical modifications and allow the product to access a large expanse of chemical space. It is still unknown how the NRPS tailoring domains are structurally accommodated into megaenzymes or how they have adapted to function in nonribosomal peptide synthesis. Here we present a series of crystal structures of the initiation module of an antibiotic-producing NRPS, linear gramicidin synthetase. This module includes the specialized tailoring formylation domain, and states are captured that represent every major step of the assembly-line synthesis in the initiation module. The transitions between conformations are large in scale, with both the peptidyl carrier protein domain and the adenylation subdomain undergoing huge movements to transport substrate between distal active sites. The structures highlight the great versatility of NRPSs, as small domains repurpose and recycle their limited interfaces to interact with their various binding partners. Understanding tailoring domains is important if NRPSs are to be utilized in the production of novel therapeutics.

Indexed as

BiocatalysisAmino Acid IsomerasesAnti-Bacterial AgentsBinding SitesBrevibacillusCarbohydrate MetabolismCarrier ProteinsCatalytic DomainCoenzymesCrystallography, X-RayGramicidinHydroxymethyl and Formyl TransferasesModels, MolecularMultienzyme ComplexesPantetheinePeptide Synthases4'-phosphopantetheineAmino Acid IsomerasesAnti-Bacterial AgentsCarrier ProteinsCoenzymesGramicidingramicidin-S-synthetase 2Hydroxymethyl and Formyl TransferasesMultienzyme Complexesnon-ribosomal peptide synthasePantetheinePeptide SynthasesRNA, Transfer

Identifiers

PMID26762462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.